ClinicalTrials.Veeva

Menu
A

Albuquerque Clinical Trials | Albuquerque, NM

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Galcanezumab
Atogepant
Methotrexate
Baricitinib
Metformin
Tanezumab
MK-7264
Ranolazine
Bococizumab
Gefapixant

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

16 of 139 total trials

53-Week Study Evaluating the Safety and Efficacy of Intra-articular Injections of TPX-100 With Mild to Severe Tibio-Femoral Osteoarthritis of the Knee

53-Week Study Evaluating the Safety and Efficacy of Intra-articular (IA) Injections of TPX-100 vs Placebo in Subjects with Mild to Severe Tibio-Femor...

Enrolling
Osteoarthritis (OA) of the Knee
Drug: TPX-100 200mg, Once weekly for 4 weeks
Other: PBS

This is a 26-week, multi-center, randomized, double-blind, placebo-controlled study with a 4-week treatment-free Safety Follow-up period to assess th...

Enrolling
Chronic Idiopathic Constipation (CIC)
Drug: Tenapanor 50 mg BID
Drug: Tenapanor 5 mg BID

This study compares insulin icodec, an insulin taken once a week to insulin glargine, an insulin taken once a day. The study medicine will be investi...

Enrolling
Diabetes Mellitus, Type 1
Drug: Insulin glargine
Drug: Insulin icodec

The purpose of this study was to assess efficacy, including inhibition of radiographic progression, and safety with upadacitinib versus placebo and v...

Active, not recruiting
Rheumatoid Arthritis
Drug: Placebo for Upadacitinib
Drug: Upadacitinib

A study evaluating the efficacy, safety, tolerability, pharmacokinetics (PK), and pharmacodynamics (PD) of GLPG3667 administered orally once daily fo...

Active, not recruiting
Systemic Lupus Erythematosus
Drug: GLPG3667
Drug: Placebo

This study is testing whether a new medication called CX11 works and is safe for participants with type 2 diabetes who have not reached good blood su...

Not yet enrolling
Type II Diabetes Mellitus
Other: Placebo
Drug: CX11

The main purpose of this study is to evaluate the efficacy and safety of eloralintide compared with placebo for body weight reduction in participants...

Enrolling
Overweight
Obesity
Drug: Eloralintide
Drug: Placebo

The purpose of this study is to evaluate the efficacy and safety of eloralintide in adults with obesity or overweight who do not have type 2 diabetes...

Not yet enrolling
Overweight
Obesity
Drug: Placebo
Drug: Eloralintide

The primary objective of this study is to describe the long-term safety and tolerability of rocatinlimab in participants with moderate-to-severe AD.

Active, not recruiting
Atopic Dermatitis
Other: Placebo
Drug: Rocatinlimab

The primary objectives of this study are to evaluate the safety and reactogenicity of mRNA-1403, and to demonstrate the efficacy of mRNA-1403 to prev...

Enrolling
Acute Gastroenteritis
Norovirus Acute Gastroenteritis
Biological: mRNA-1403
Biological: Placebo

The purpose of the study is to learn about how effective, safe, and tolerable the Clostridioides difficile (C. difficile) vaccine is in decreasing th...

Enrolling
Clostridioides Difficile Associated Disease
Biological: C.difficile vaccine
Other: Saline Placebo

This study is designed to find out how well the COVID-19 vaccine protects people 50 to 64, who don't have any serious health problems, compared to a...

Enrolling
COVID-19
SARS-COV-2 Infection
Biological: Placebo
Biological: BNT162b2 Vaccine

The purpose of this study is to measure how well taking lebrikizumab alone works for participants with fewer places on the body with eczema (atopic d...

Enrolling
Atopic Dermatitis
Drug: Lebrikizumab

This post-market study will assess the performance of and user satisfaction with the PureWick™ Male External Catheter in a home setting. The study wi...

Invitation-only
Urinary Incontinence
Device: UltraFlex Self-Adhering Male External Catheter
Device: PureWick System

A randomized, double-blind, international multicenter, colchicine and placebo-controlled study to evaluate the efficacy and safety of ABP-745 in subj...

Enrolling
Acute Gouty Arthritis
Gout Flare
Drug: Placebo
Drug: Colchicine

A migraine is a moderate to severe headache typically on one side of the head. A migraine attack is a headache that may be accompanied by throbbing,...

Enrolling
Migraine
Drug: Ubrogepant
Drug: Placebo for Ubrogepant

Trial sponsors

Pfizer logo
Lilly logo
AbbVie logo
Allergan logo
Bristol-Myers Squibb (BMS) logo
Gilead Sciences logo
Merck Sharp & Dohme (MSD) logo
Amgen logo
S
Astellas logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems